Tyndall Capital Partners L P

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
1
Total Value
411943
Accession Number
0001641172-25-010920
Form Type
13F-HR
Manager Name
Tyndall Capital Partners L P
Data Enrichment
100% identified
1 identified0 unidentified

Holdings

1 positions
Manager:
Search and click to pin securities to the top
Cyclerion Therapeutics, Inc.
Shares:
164777(+0.0%)
Value:
$411.9M(-22.4%)